Showing results (41-50 of 63) with videos related to
Sort By:
Pageof 7
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 22, 2008
Relationship between drug/metabolite exposure and impairment of excretory transport functionMaciej J Zamek-Gliszczynski, J Cory Kalvass, Gary M Pollack, et al.The Journal of Pharmacology and Experimental Therapeutics|August 11, 2004
Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systemsKeith A Hoffmaster, Maciej J Zamek-Gliszczynski, Gary M Pollack, et al.Clinical Pharmacology in Drug Development|April 30, 2016
A food effect study and dose proportionality study to assess the pharmacokinetics and safety of bardoxolone methyl in healthy volunteersNathan S Teuscher, Richard J Kelley, Emily O Dumas, et al.The Journal of Pharmacology and Experimental Therapeutics|July 25, 2007
Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50,u and correlation of in vitro, preclinical, and clinical dataJ Cory Kalvass, Emily R Olson, Michael P Cassidy, et al.The Journal of Pharmacology and Experimental Therapeutics|May 13, 2006
Hepatobiliary disposition of a drug/metabolite pair: Comprehensive pharmacokinetic modeling in sandwich-cultured rat hepatocytesRyan Z Turncliff, Keith A Hoffmaster, J Cory Kalvass, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 9, 2002
Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatmentHao Xiong, Hiroshi Suzuki, Yuichi Sugiyama, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 20, 2008
Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrierBjörn Bauer, Anika M S Hartz, Jonathan R Lucking, et al.Plos One|June 1, 2018
Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimensAparna Vasanthakumar, Justin W Davis, Manal Abunimeh, et al.The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
Pharmacokinetics of 5 (and 6)-carboxy-2',7'-dichlorofluorescein and its diacetate promoiety in the liverMaciej J Zamek-Gliszczynski, Hao Xiong, Nita J Patel, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 11, 2009
Breast cancer resistance protein interacts with various compounds in vitro, but plays a minor role in substrate efflux at the blood-brain barrierRong Zhao, Thomas J Raub, Geri A Sawada, et al.Pageof 7